Our collaborative work with Dr. Gold and his team underscores the potential of combining blood biomarkers and brain imaging to identify early signs of vascular contributions to cognitive decline. By measuring levels of S100b, an indirect marker of blood-brain barrier leakage, and pairing it with advanced neuroimaging, we identified patterns associated with memory loss in older adults. The findings underscore how a multimodal approach can better predict who’s at risk for vascular cognitive impairment and dementia (VCID).
Manekya presents in PS Seminar Series
Manekya presented her fourth-year PhD seminar in the Pharmaceutical Sciences Seminar Series. Her presentation focused on targeting neuroinflammatory pathways to restore blood-brain barrier integrity in drug-resistant epilepsy.
September 1, 2026
